# LANSOPRAZOLE
> **ANDA207167** · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA LTD · Approved 2023-03-28
## Drug
- **FDA Application Number:** ANDA207167
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LANSOPRAZOLE
- **Generic name:** LANSOPRAZOLE
- **Active ingredients:** LANSOPRAZOLE
- **Dosage form:** TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** AUROBINDO PHARMA LTD
- **Manufacturer:** NorthStar Rx LLC
- **First approval:** 2023-03-28
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207167)
---
*AI Analytics · CC0 1.0*